CAVERJECT

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Malta, Mexico, New Zealand, Singapore, South Africa, Spain, UK.

Active ingredients

The drug CAVERJECT contains one active pharmaceutical ingredient (API):

1	Alprostadil UNII F5TD010360 - ALPROSTADIL
	Alprostadil is chemically identical to prostaglandin E1, the actions of which include vasodilatation of blood vessels in the erectile tissues of the corpora cavernosa and increase in cavernosal artery blood flow, causing penile rigidity.
	Read more about Alprostadil

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CAVERJECT Powder for solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04BE01	Alprostadil	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	4579B, 4580C
BR	Câmara de Regulação do Mercado de Medicamentos	522720030084107, 522720030084207
CA	Health Products and Food Branch	02215187, 02215756
EE	Ravimiamet	1021925, 1023769, 1700817, 1705979, 1708365, 1708376, 1717343, 1717354, 1723890, 1730326, 1798948, 1810976, 1813834, 1813845, 1816781, 1872558
ES	Centro de información online de medicamentos de la AEMPS	60535, 60911
FI	Lääkealan turvallisuus- ja kehittämiskeskus	000552, 000784
FR	Base de données publique des médicaments	65613168, 68594342
GB	Medicines & Healthcare Products Regulatory Agency	34520, 37144, 37151, 38573, 38597
HK	Department of Health Drug Office	50155
IE	Health Products Regulatory Authority	16886, 76760
MT	Medicines Authority	AA505/07902
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	332M95
NZ	Medicines and Medical Devices Safety Authority	15633, 15634
SG	Health Sciences Authority	08097P, 08718P
US	FDA, National Drug Code	0009-3701, 0009-5181, 0009-5182, 0009-7686, 63539-121, 63539-221
ZA	Health Products Regulatory Authority	28/7.1/0329